Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;5(3):484-91.
doi: 10.1158/1940-6207.CAPR-11-0414. Epub 2011 Dec 5.

ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches

Affiliations

ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches

Hua Li et al. Cancer Prev Res (Phila). 2012 Mar.

Abstract

Epithelial ovarian cancer (EOC) remains the most lethal gynecologic malignancy in the United States. EZH2 silences gene expression through trimethylating lysine 27 on histone H3 (H3K27Me3). EZH2 is often overexpressed in EOC and has been suggested as a target for EOC intervention. However, EZH2 target genes in EOC remain poorly understood. Here, we mapped the genomic loci occupied by EZH2/H3K27Me3 using chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) and globally profiled gene expression in EZH2-knockdown EOC cells. Cross-examination of gene expression and ChIP-seq revealed a list of 60 EZH2 direct target genes whose expression was upregulated more than 1.5-fold upon EZH2 knockdown. For three selected genes (ALDH1A1, SSTR1, and DACT3), we validated their upregulation upon EZH2 knockdown and confirmed the binding of EZH2/H3K27Me3 to their genomic loci. Furthermore, the presence of H3K27Me3 at the genomic loci of these EZH2 target genes was dependent upon EZH2. Interestingly, expression of ALDH1A1, a putative marker for EOC stem cells, was significantly downregulated in high-grade serous EOC (n = 53) compared with ovarian surface epithelial cells (n = 10, P < 0.001). Notably, expression of ALDH1A1 negatively correlated with expression of EZH2 (n = 63, Spearman r = -0.41, P < 0.001). Thus, we identified a list of 60 EZH2 target genes and established that ALDH1A1 is a novel EZH2 target gene in EOC cells. Our results suggest a role for EZH2 in regulating EOC stem cell equilibrium via regulation of ALDH1A1 expression.

PubMed Disclaimer

Conflict of interest statement

Disclosure of potential conflicts of interest: CLC and PJT are employees and stockholders of GlaxoSmithKline Pharmaceuticals.

Figures

Figure 1
Figure 1. Identification of EZH2 target genes in human SKOV3 EOC cells
(A) SKOV3 cells were infected with indicated lentivirus encoding shEZH2 or control. Drug-selected cells were examined for expression of EZH2, H3K27Me3 and GAPDH by immunoblotting analysis using indicated antibodies. (B) Schematic of experimental strategies used to identify EZH2 target genes. Genes whose expression was upregulated >1.5-fold upon EZH2 knockdown by two individual shEZH2 were identified by global gene expression microarray analysis. Genomic loci occupied by EZH2/H3K27Me3 were profiled by ChIP-seq analysis. (C) Cross-examination of gene expression profiling and ChIP-seq analysis as illustrated in (B) revealed a list of 60 putative EZH2 target genes in human SKOV3 EOC cells.
Figure 2
Figure 2. Validation of upregulation of the selected EZH2 silenced target genes in SKOV3 human EOC cells upon EZH2 knockdown by qRT-PCR
(A) SKOV3 cells were infected with lentivirus encoding the indicated shEZH2s or control. After drug selection, mRNA was extracted and examined for expression of ALDH1A1 mRNA by qRT-PCR. Expression of β-2-microglobulin was used to normalize the expression of ALDH1A1 mRNA. * p < 0.05 compared with controls. (B) Same as (A), but for SSTR1 mRNA expression. * p < 0.05 compared with controls. (C) Same as (A), but for DACT3 mRNA expression. * p < 0.05 compared with controls.
Figure 3
Figure 3. Validation of occupancy of the genomic loci of the selected EZH2 target genes by EZH2 and H3K27Me3 in SKOV3 human EOC cells using ChIP analysis
Control and shEZH2 #2 expressing SKOV3 cells were subjected to ChIP analysis using antibodies specific to EZH2 or H3K27Me3, respectively. An isotype matched IgG was used as a negative control, and an antibody specific to core histone H3 was used as a positive control. After ChIP analysis, the genomic loci of the indicated genes were subjected to PCR amplification using primers detailed in materials and methods. Please see Figure 1A for shEZH2 knockdown efficacy. Shown are representative images of 3 independent experiments. Note that for H3K27Me3 ChIP, a low number of PCR cycles were used compared with EZH2 or histone H3 ChIP to avoid over saturation of signals.
Figure 4
Figure 4. EZH2 targets ALDH1A1 in high-grade serous subtype EOC
(A) Relative expression of EZH2 mRNA in 53 cases of laser capture and microdissected (LCM) high-grade serous EOC and 10 individual isolations of normal human ovarian surface epithelial (HOSE) cells. (B) Quantitation of (A), * p < 0.001 compared with high-grade serous EOC. (C) Same as (A), but for relative expression of ALDH1A1 mRNA. (D) Quantitation of (C), * p < 0.001 compared with high-grade serous EOC. (E) Correlation between expression of ALDH1A1 and EZH2 as determined by Spearman’s statistical analysis using GraphPad Prism version 5.0 software.

Similar articles

  • Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
    Li H, Cai Q, Godwin AK, Zhang R. Li H, et al. Mol Cancer Res. 2010 Dec;8(12):1610-8. doi: 10.1158/1541-7786.MCR-10-0398. Epub 2010 Nov 29. Mol Cancer Res. 2010. PMID: 21115743 Free PMC article.
  • NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells.
    Garipov A, Li H, Bitler BG, Thapa RJ, Balachandran S, Zhang R. Garipov A, et al. Mol Cancer Res. 2013 Apr;11(4):360-9. doi: 10.1158/1541-7786.MCR-12-0661. Epub 2013 Jan 29. Mol Cancer Res. 2013. PMID: 23360797 Free PMC article.
  • EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Fu Y, Chen J, Pang B, Li C, Zhao J, Shen K. Fu Y, et al. Cell Biochem Biophys. 2015 Jan;71(1):105-12. doi: 10.1007/s12013-014-0168-1. Cell Biochem Biophys. 2015. PMID: 25077680
  • Aberrations of EZH2 in cancer.
    Chase A, Cross NC. Chase A, et al. Clin Cancer Res. 2011 May 1;17(9):2613-8. doi: 10.1158/1078-0432.CCR-10-2156. Epub 2011 Mar 2. Clin Cancer Res. 2011. PMID: 21367748 Review.
  • Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
    Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G; Australian Cancer Study; Australian Ovarian Cancer Study Group; Baker H, Bandera EV, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, Bogdanova N, Brinton L, Brooks-Wilson A, Butzow R, Campbell I, Carty K, Chang-Claude J, Chen YA, Chen Z, Cook LS, Cramer D, Cunningham JM, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Dicks E, Doherty JA, Dörk T, du Bois A, Dürst M, Eccles D, Easton DF, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Goode EL, Goodman MT, Grownwald J, Harrington P, Harter P, Hein A, Heitz F, Hildebrandt MA, Hillemanns P, Hogdall E, Hogdall CK, Hosono S, Iversen ES, Jakubowska A, Paul J, Jensen A, Ji BT, Karlan BY, Kjaer SK, Kelemen LE, Kellar M, Kelley J, Kiemeney LA, Krakstad C, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Lu K, Lubinski J, Lundvall L, Massuger L, Matsuo K, McGuire V, McLaughlin JR, McNeish IA, Menon U, Modugno F, Moysich KB, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Odunsi K, Olson SH, Orlow I, Orsulic S, Weber RP, Pear… See abstract for full author list ➔ Kar SP, et al. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1574-84. doi: 10.1158/1055-9965.EPI-14-1270. Epub 2015 Jul 24. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26209509 Free PMC article. Review.

Cited by

References

    1. Farley J, Ozbun LL, Birrer MJ. Genomic analysis of epithelial ovarian cancer. Cell Res. 2008;18:538–548. - PMC - PubMed
    1. Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511–1518. - PMC - PubMed
    1. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science. 2002;298:1039–1043. - PubMed
    1. Li H, Cai Q, Godwin AK, Zhang R. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Mol Cancer Res. 2010;8:1610–1618. - PMC - PubMed
    1. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010;18:185–197. - PMC - PubMed

Publication types

MeSH terms